A certified one-hour live webinar for radiologists, radiologic technologists, radiology administrators, and practice managers
In February 2011, the FDA approved digital breast tomosynthesis (DBT) for use in breast imaging. The approval of DBT adds to the already wide range of breast screening and diagnostic imaging options available to physicians.
With FDA approval of DBT, the medical community is faced with evaluating DBT in terms of providing improved care for their patient population and the impact of this new technology on their medical practice. This evaluation process involves consideration of the pros and cons of the technology compared to their current practice, operational concerns, and impact on patient care.
At the conclusion of this activity, participants should be better able to:
Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the International Center for Postgraduate Medical Education.The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Radiologic Technologists and Radiology Administrators
This program has been approved by AHRA: The Association for Medical Imaging Management for 1.0 of ARRT Category A CE credit.
Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.
Dr. Destounis joined Elizabeth Wende Breast Care (EWBC) in Rochester, NY in 1993 after completing her Diagnostic Radiology Residency at the University of Rochester School of Medicine and Dentistry. She completed a breast imaging fellowship at EWBC with Dr. Wende Logan-Young and subsequently joined the faculty.
Dr. Destounis sits on the medical advisory boards of several breast imaging technology companies and is also a member of the American Cancer Society Medical Advisory Team. Within the Rochester community, Dr. Destounis has participated on radiology committees for several health care providers and is a volunteer for many community organizations. Dr. Destounis frequently lectures nationally and internationally to professional groups on a variety of radiological subjects, including mammography, ultrasound, MRI, biopsy techniques, and new modalities like elastography and digital breast tomosynthesis.
In 2010, Dr. Destounis was selected as a distinguished Fellow of the Society of Breast Imaging (SBI). This honor is given to Members of the Society for pursuing academic excellence, promoting teaching, education and research. In May 2011, Dr. Destounis was also honored as a Fellow by the American College of Radiology.
Dr. Destounis’ research interests include computer-aided detection, digital mammography, breast MRI, breast ultrasound, and breast biopsy. She has published several clinical and research peer-reviewed articles and is the principal investigator of several ongoing research projects.
The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty below have reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Stamatia Destounis, MD, FACR has performed contracted research for Hologic, Inc.
The planners and managers below reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Sharon Cancino
Laura Excell, ND, NP, MS, MA, LPC, NCC
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD
Linda McLean, MS
Victoria Phoenix, BS
Lisa Schleelein, MEd
Patricia Staples, MSN, NP-C, CCRN
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME, and Hologic. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10
JOINTLY SPONSORED BY
THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.